Clinical Trial Update: Neoadjuvant Chemoimmunotherapy and Extrafascial Hysterectomy for IB2 Cervical Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial assessing neoadjuvant chemoimmunotherapy followed by extrafascial hysterectomy for IB2 cervical cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Snippet

Sponsor: Tongji Hospital | Conditions: Cervical Cancer, Neoadjuvant Chemoimmunotherapy | Phase 2 | Status: RECRUITING